References
- JemalASiegelRWardEHaoYXuJThunMJCancer statistics, 2009CA Cancer J Clin200959422524919474385
- ChauhanSCKumarDJaggiMMucins in ovarian cancer diagnosis and therapyJ Ovarian Res200922120034397
- ArmstrongDKRelapsed ovarian cancer: challenges and management strategies for a chronic diseaseOncologist20027Suppl 5202812324630
- SingalPKIliskovicNDoxorubicin-induced cardiomyopathyN Engl J Med1998339139009059744975
- BuzdarAUMarcusCSmithTLBlumenscheinGREarly and delayed clinical cardiotoxicity of doxorubicinCancer19855512276127653922612
- YallapuMMJaggiMChauhanSCScope of nanotechnology in ovarian cancer therapeuticsJ Ovarian Res201031920691083
- MinottiGMennaPSalvatorelliECairoGGianniLAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityPharmacol Rev200456218522915169927
- BillinghamMEMasonJWBristowMRDanielsJRAnthracycline cardiomyopathy monitored by morphologic changesCancer Treat Rep1978626865872667860
- LabialleSGayetLMarthinetERigalDBaggettoLGTranscriptional regulators of the human multidrug resistance 1 gene: recent viewsBiochem Pharmacol2002645–694394812213590
- ScatenaCDStewartZAMaysDMitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrestJ Biol Chem19982734630777307849804855
- DantzigAHShepardRLCaoJReversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979Cancer Res19965618417141798797588
- IgneyFHKrammerPHDeath and anti-death: tumour resistance to apoptosisNat Rev Cancer20022427728812001989
- GrossAMitochondrial carrier homolog 2: a clue to cracking the BCL-2 family riddle?J Bioenerg Biomembr200537311311916167168
- DecaudinDGeleySHirschTBcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agentsCancer Res199757162678988042
- LimaRTMartinsLMGuimarãesJESambadeCVasconcelosMHSpecific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cellsCancer Gene Ther200411530931615031723
- CaoNChengDZouSAiHGaoJShuaiXThe synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cellsBiomaterials20113282222223221186059
- HaleyBFrenkelENanoparticles for drug delivery in cancer treatmentUrol Oncol2008261576418190833
- WangYGaoSYeWHYoonHSYangYYCo-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymerNat Mater200651079179616998471
- ZhuCJungSLuoSCo-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymersBiomaterials20103182408241619963269
- QiuLYBaeYHSelf-assembled polyethylenimine-graft-poly (ɛ-caprolactone) micelles as potential dual carriers of genes and anticancer drugsBiomaterials200728284132414217582489
- ChengDCaoNChenJYuXShuaiXMultifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in ratBiomaterials20123341170117922061491
- ShuaiXTMerdanTUngerFWittmarMKisselTNovel biodegradable ternary copolymers hy-PEI-g-PCL-b-PEG: synthesis, characterization, and potential as efficient nonviral gene delivery vectorsMacromolecules2003361557515759
- CammasSNagasakiYKataokaKHeterobifunctional poly(ethylene oxide): synthesis of α-methoxy-ω-amino and α-hydroxy-ω-amino PEOs with the same molecular weightsBioconjug Chem1995622262307599266
- MukhopadhyayPBátkaiSRajeshMPharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicityJ Am Coll Cardiol200750652853617678736
- ChenGHChenWJWuZMRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppressionBiomaterials200930101962197019162315
- WangDANarangASKotbMNovel branched poly(ethylenimine)- cholesterol water-soluble lipopolymers for gene deliveryBiomacromolecules2002361197120712425656
- PanaretakisTPokrovskajaKShoshanMCGrandérDActivation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicinJ Biol Chem200227746443174432612193597
- GiulianoMLauricellaMVassalloECarabilloMVentoRTesoriereGInduction of apoptosis in human retinoblastoma cells by topoisomerase inhibitorsInvest Ophthalmol Vis Sci1998398130013119660477
- PoulakiVMitsiadesCSJoussenAMLappasAKirchhofBMitsiadesNConstitutive nuclear factor-kB activity is crucial for human retinoblastoma cell viabilityAm J Pathol200216162229224012466137
- WangSKonorevEAKotamrajuSJosephJKalivendiSKalyanaramanBDoxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H2O2- and p53-dependent pathwaysJ Biol Chem200427924255352554315054096
- NicholsonDWThornberryNACaspases: killer proteasesTrends Biochem Sci19972282993069270303
- PetersenHFechnerPMMartinALPolyethylenimine-graft- poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery systemBioconjug Chem200213484585412121141
- SudimackJLeeRJTargeted drug delivery via the folate receptorAdv Drug Deliv Rev200041214716210699311
- LowPSHenneWADoorneweerdDDDiscovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseasesAcc Chem Res200841112012917655275
- ClementiMEGiardinaBDi StasioEMordenteAMisitiFDoxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondriaAnticancer Res2003233B2445245012894526
- KalivendiSVKotamrajuSZhaoHJosephJKalyanaramanBDoxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase. Effect of antiapoptotic antioxidants and calciumJ Biol Chem200127650472664727611579094
- GamenSAnelAPerez-GalanPDoxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cellsExp Cell Res2000258122323510912804
- ChenYWanYWangYZhangHJiaoZAnticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticlesInt J Nanomedicine201162321232622072869
- PanaretakisTLaaneEPokrovskajaKDoxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosisMol Biol Cell20051683821383115917298
- DecaudinDGeleySHirschTBcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agentsCancer Res199757162678988042
- JurgensmeierJMXieZDeverauxQEllerbyLBredesenDReedJCBax directly induces release of cytochrome c from isolated mitochondriaProc Natl Acad Sci U S A1998959499750029560217
- LiPNijhawanDBudihardjoICytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascadeCell19979144794899390557
- MurphyKMRanganathanVFarnsworthMLKavallarisMLockRBBcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cellsCell Death Differ20007110211110713725
- OltvaiZNMillimanCLKorsmeyerSJBcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell deathCell19937446096198358790
- GrossAJockelJWeiMCKorsmeyerSJEnforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosisEMBO J19981714387838859670005